Sign In
Buy MED
$10.62
-0.400 (-3.63%)
At Close: Jun 23, 2026
Medifast: Looking Attractively Valued Even Amidst Declining Fundamentals
02:29pm, Wednesday, 12'th Apr 2023
Medifast stock was truly exceptional, as it embodied the desirable traits of value, growth, and dividend stocks all in one. However, latest quarterly earnings were down around 10% YoY.
Dividend Growth Investing Like Peter Lynch
09:00am, Friday, 07'th Apr 2023
Although Peter Lynch wasn't explicitly a dividend growth investor, his principles and advice are highly applicable to a dividend growth strategy. Certain categories and sectors of stocks work better f
Medifast: A High Yield But Low Portfolio Size Hold For Me
08:21am, Monday, 03'rd Apr 2023
The latest dividend yields over 6% on its market price. The latest dividend payout is less than 50% of its latest quarter earnings.
Medifast: An Attractive Dividend But Operating Results Need Further Improvement
06:28am, Wednesday, 22'nd Mar 2023
Medifast operates in the health and wellness industry and is the owner of the OPTAVIA brand, a popular weight loss and diet program. The company generates its sales through a large network of independ
March's 5 Dividend Growth Stocks With 5.73%+ Yields
05:54pm, Friday, 17'th Mar 2023
After a strong start to the year, February pulled us back down to reality. Asset prices have again dropped due to expectations of higher interest rates for longer.
Medifast (MED) Stock Down Despite Q4 Earnings, Sales Beat
10:32am, Wednesday, 22'nd Feb 2023
Medifast's (MED) fourth-quarter 2022 results reflect reduced Coach productivity and cost inflation. While earnings increase year over year, revenues dip
Medifast, Inc. (MED) Q4 2022 Earnings Call Transcript
10:37pm, Tuesday, 21'st Feb 2023
Medifast, Inc. (NYSE:MED ) Q4 2022 Earnings Conference Call February 21, 2023 4:30 PM ET Company Participants Reed Anderson - Investor Relations, ICR, Inc. Dan Chard - Chief Executive Officer Jim Malo
Medifast (MED) Tops Q4 Earnings and Revenue Estimates
06:49pm, Tuesday, 21'st Feb 2023
Medifast (MED) delivered earnings and revenue surprises of 69.72% and 9.96%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
February's 5 Dividend Growth Stocks With 5.43%+ Yields
11:45am, Friday, 17'th Feb 2023
The market has started off 2023 with a strong run across most of the major indexes. With an uncertain future, dividend growth stocks can be one place to consider investing in to generate returns.
Medifast (MED) Readies for Q4 Earnings: Everything to Note
09:47am, Thursday, 16'th Feb 2023
Medifast's (MED) fourth-quarter results are likely to reflect the adverse impacts of increased cost inflation, while strength in the OPTAVIA lifestyle solution and coaching support system bodes well.
7 Undervalued Reddit Stocks to Buy Now
03:53pm, Tuesday, 20'th Dec 2022
Despite the frenzy over meme stocks dying down a while ago, plenty of undervalued Reddit stocks are available for investors to pick up. Reddit's social media platform hosts one of the largest communit
7 Ridiculously Cheap Stocks Yielding 5% in 2023
06:30am, Tuesday, 20'th Dec 2022
In 2023, stock market uncertainties will worsen, rewarding investors who seek cheap dividend stocks. The bigger their discount to their fair value, the more margin of safety the company offers.
Medifast Stock Shows Promise At Current Valuation
12:00am, Friday, 09'th Dec 2022
Medifast is a health and wellness company that has fallen more than 40% YTD and is more than 60% off its 5 year average P/E and EV/EBITDA. The stock's decline is an overreaction to fears that growth w
Got $1,000? 2 Ultra High-Yield Dividend Stocks to Get Your Hands On
07:30am, Saturday, 03'rd Dec 2022
These two stocks offer whopping dividend yields ranging from 5.5% to 8%.
Cash (Flow) Is King: 2 Cash-Rich High Yielders To Weather The Storm
08:05am, Wednesday, 16'th Nov 2022
Hedge fund manager and billionaire Ray Dalio recently changed his view that "cash is trash." But if investors had taken Dalio's advice before, they would have no cash with which to invest in his new r
